← 返回 Skills 市场

Gilead Pharma

Name: Gilead Pharma
Author: hanxueyuan

作者 hanxueyuan · GitHub ↗ · v1.0.0 · MIT-0

cross-platform ✓ 安全检测通过

总下载

当前安装

版本数

在 OpenClaw 中安装

/install gilead-pharma

功能描述

Gilead Pharma is a biopharmaceutical leader specializing in HIV, hepatitis C, oncology, and antiviral therapies with a strong R&D pipeline and key drugs like...

使用说明 (SKILL.md)

Gilead Sciences

Biopharmaceutical pioneer that revolutionized HIV treatment with antiretroviral therapy and later dominated hepatitis C with curative drugs.

历史时间线

1987: Michael L. Riordan founds Gilead Sciences in Foster City, California
1992: IPO on NASDAQ
2003: FDA approves Viread — key HIV antiretroviral
2006: Completa: Atripla (single-pill HIV combo) — market-leading
2013: Acquires Pharmasset for $11B; gains sofosbuvir (Sovaldi) — hepatitis C cure
2015: Harvoni (HCV combo) generates $10B+ in first year
2020: Remdesivir becomes first FDA-approved COVID-19 treatment; $30B+ revenue

商业模式

R&D-focused biopharma with specialty in antivirals. Revenue from HIV franchise (Biktarvy = #1 selling HIV drug globally), hepatitis C treatments, oncology (Yescarta CAR-T), and remdesivir. High-margin specialty drugs with patent protection. Growing oncology and cell therapy pipeline via acquisitions.

护城河分析

Dominant HIV franchise with Biktardy (single-tablet regimen, best-in-class tolerability); first-mover in hepatitis C cure; remdesivir established position in infectious disease; strong R&D pipeline in cell/gene therapy; patent cliff management via lifecycle extensions.

关键数据

revenue: $27B+ (2023)
key_drug: Biktarvy (#1 HIV drug globally)
employees: ~17,000
market_cap: ~$110B
therapeutic_areas: HIV, HCV, oncology, inflammation

有趣事实

Sovaldi (sofosbuvir) was the first drug to cure hepatitis C with a 12-week pill regimen — a disease that previously required a year of injections with terrible side effects. The drug was priced at $84,000 per course, sparking a massive pricing debate. It generated $10B+ in its first year but cured millions.

安全使用建议

This skill appears safe to install from a security perspective; treat it as general informational content and independently verify any business or medical facts before relying on them.

功能分析

Type: OpenClaw Skill Name: gilead-pharma Version: 1.0.0 The skill bundle contains purely informational and educational content regarding Gilead Sciences, covering its history, business model, and key pharmaceutical products. There are no executable code segments, suspicious instructions, or indicators of malicious intent in SKILL.md or _meta.json.

能力评估

✓ Purpose & Capability

The artifact is coherent with its stated purpose: it provides background information about Gilead Sciences for research and analysis.

✓ Instruction Scope

The skill contains only descriptive reference content and read_when cues; it does not instruct the agent to run commands, access accounts, change data, or override user intent.

✓ Install Mechanism

There is no install specification and no code files, so there is no package, script, or binary installation behavior to review.

✓ Credentials

The registry declares no required binaries, environment variables, credentials, config paths, or OS-specific capabilities.

✓ Persistence & Privilege

The artifacts show no persistence, background activity, credential use, local file access, memory writes, or privileged operations.

如何使用

确保已安装 OpenClaw（本地或 Docker 部署）
在对话框中输入安装命令：/install gilead-pharma
安装完成后，直接呼叫该 Skill 的名称或使用 /gilead-pharma 触发
根据 Skill 的参数说明提供必要输入，即可获得结构化输出

版本历史

v1.0.0

Gilead Sciences skill – initial release: - Summarizes Gilead’s pioneering role in HIV and hepatitis C drug development. - Includes a timeline of key company milestones from 1987 to 2020. - Outlines the business model, dominant drug franchises, and pipeline strategy. - Provides moat analysis and essential company data (revenue, workforce, market cap). - Highlights notable facts, including Sovaldi’s impact on hepatitis C and drug pricing debates.

元数据

Slug gilead-pharma

版本 1.0.0

许可证 MIT-0

累计安装 0

当前安装数 0

历史版本数 1

常见问题

Gilead Pharma 是什么？

Gilead Pharma is a biopharmaceutical leader specializing in HIV, hepatitis C, oncology, and antiviral therapies with a strong R&D pipeline and key drugs like... 它是一个面向 Claude Code / OpenClaw 的 AI Agent Skill 插件，目前累计下载 15 次。

如何安装 Gilead Pharma？

在 OpenClaw 或 Claude Code 对话框中运行命令「/install gilead-pharma」即可一键安装，无需额外配置。

Gilead Pharma 是免费的吗？

是的，Gilead Pharma 完全免费，采用 MIT-0 许可证，可自由下载、安装和使用。

Gilead Pharma 支持哪些平台？

Gilead Pharma 跨平台运行，可在任意部署了 OpenClaw / Claude Code 的环境中使用（cross-platform）。

谁开发了 Gilead Pharma？

由 hanxueyuan（@hanxueyuan）开发并维护，当前版本 v1.0.0。